A drug used for gout could also be used to protect people with diabetes from heart disease, researchers have revealed.
The drug, allopurinol, has been in use for 50 years.
Now researchers say it can help protect the wall of the heart muscle from thickening in patients with type 2 diabetes, a problem known as left ventricular hypertrophy.
It is thought this would help prevent heart disease in these patients.
The researchers at Dundee University, Scotland say their earlier work has shown the drug could help people with heart failure and angina and those who have suffered a stroke.
The findings come from a study of some 66 patients. Half took the drug for nine months and the other half a placebo.
This allowed the researchers to test the effects of the drug on the thickness of the muscle wall.
The findings have been reported in the Journal of the American College of Cardiology.
Researcher Dr Jacob George said: "If a larger-scale study backs up these findings then there is reason to be excited about the potential for using allopurinol as a therapy to reduce cardiovascular events in patients with Type II diabetes. It has been on the market for decades so is cheap and safe and our research suggests it is a way of treating left ventricular hypertrophy without lowering blood pressure."
He added: “This is another piece of the large jigsaw we’ve been putting together in Dundee for over the last 20 years. We have shown that allopurinol has potential in heart failure, coronary artery disease, stroke and now diabetes patients. We are building a body of evidence that will allow us to determine whether putting patients on high doses of allopurinol is a realistic way of significantly reducing cardiovascular mortality.”
Journal of the American College of Cardiology 29 August 2013

Leave a Reply